Document is current
Any future updates will be listed below
-
Authors
Heck, Katharina
Hatz, Katja
Cattaneo, Marco
Pfister, Isabel
Magnin, Simon
Ruscitti, Ludovico
Stasik, Isabel
Tillmann, Anne
Shamshiev, Marat
Fang, Joseph
Weinberger, Andreas
Zweifel, Sandrine A.
Garweg, Justus G.
Eandi, Chiara M.
Grimaldi, Gabriela
Munk, Marion R.
Somfai, Gabor M.
Ambresin, Aude
Feltgen, Nicolas https://orcid.org/0000-0002-6857-3003
- License Information
-
More Information
Article History
Received: 4 May 2026
Accepted: 11 June 2026
First Online: 23 June 2026
Declarations
:
: Katja Hatz: Advisory board participant and lecturer for Apellis, Bayer, Roche, AbbVie/Allergan, Astellas, Sandoz; contract research and/or grant support for Bayer, Roche, AbbVie/Allergan, ONL Therapeutics, Merck. Andreas Weinberger: Paid consultant and/or lecturer for AbbVie, Appelis, Bayer, Roche, Sandoz. Sandrine A. Zweifel: Consultant and advisor for Alcon, Allergan, Apellis, Bayer, Endogena, Novartis, Roche, and Zeiss and grant support from Bayer, Novartis, and Roche outside the submitted work. Justus G. Garweg: Advisor and speaker for several pharmaceutical companies. Contributes to several international industry-sponsored clinical studies in the fields of retinal disease and uveitis (AbbVie, Bayer, EyeBio/MSD, Roche). Grant support from Roche. Chiara M. Eandi: Advisory board participant and lecturer for AbbVie, Apellis, Astellas, Bayer, and Roche. Gabriela Grimaldi: Consultant for Apellis, Bayer, Roche. Lecturer for AbbVie, Apellis, Bayer, Roche. Grant support from Bayer and Roche. Marion R. Munk: Consultant for AbbVie, Allergan, 50 Acucela, Aviceda Therapeutics, Alimera, Bayer, Lumithera, OD-OS, Isarna Therapeutics, Roche, Novartis, Oculis, Ocuterra, genesight Therapeutics, Kubota, Böhringer-Ingelheim, Eyepoint, Ocular Therapeutix, Apellis, Astellas, Zeiss, RetinAI, Dandelion. Gabor M Somfai: Consultant for Apellis, Allergan, Bayer, Carl Zeiss, Roche. Aude Ambresin: Financial support: Roche, Bayer. Consultancy: Roche, Bayer, AbbVie, Ikerian, Appelis, Astellas. Nicolas Feltgen: Consultant for Apellis, Bayer, Roche, AbbVie. Katharina Heck, Marco Cattaneo, Isabel Pfister, Simon Magnin, Ludovico Ruscitti, Isabel Stasik, Anne Tillmann, Marat Shamshiev and Joseph Fang have nothing to disclose.
: The study was approved by all participating ethics committees, led by the Ethics Committee of the canton of Berne (registration no. 2024–01026). Coded patient data were included based on general or specific informed consent, in line with the International Council for Harmonisation Good Clinical Practice (ICH-GCP) E6 guidelines, the Declaration of Helsinki, and Swiss law.
